Vicki Moore, PhD

Contributing Writer https://www.oncologynurseadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Gastrointestinal Cancer

Trends in Age-Based Incidence of Esophageal Adenocarcinoma Over Time

Vicki Moore, PhD

January 7, 2021

Population-based analysis identified trends in incidence and disease-free survival for patients with advanced-stage carcinoma across 3 age groups.

Pathologist examining test tube samples in lab.

Multiple Myeloma

Laboratory Markers Found to Correlate With Symptom Burden in Relapsed/Refractory Multiple Myeloma

Vicki Moore, PhD

January 5, 2021

Study finds correlation between certain laboratory markers and symptom burden in patients with relapsed/refractory multiple myeloma.

Breast Cancer

Influence of Health Literacy of Informal Caregivers on Patient Outcomes

Vicki Moore, PhD

December 24, 2020

An analysis of patient outcomes revealed links between depression and HRQOL in patients with their informal caregivers’ level of health literacy.

A patient with cancer waits for treatment.

General Oncology

Assessment of Hospital Readmissions in Patients Using an Oncology Service

Vicki Moore, PhD

December 22, 2020

A retrospective review of charts showed a high percentage of readmissions on an oncology service and 2 potential strategies for reducing this rate.

Reviewing a prescription with an older patient.

Myeloproliferative Neoplasms

Direct Oral Anticoagulants as Effective as Vitamin K Antagonists for Thromboembolic Events With Myeloproliferative Neoplasms

Vicki Moore, PhD

December 10, 2020

The efficacy and safety of direct oral anticoagulants and vitamin K antagonists in the treatment of ATEs/VTEs in patients with MPNs was compared.

Side-Effect Management

Treatment-Related Toxicities and Overnight Fasting Before Lapatinib Administration

Vicki Moore, PhD

December 8, 2020

Researchers compared adverse effect incidence with lapatinib administration at 3 different times of the day.

General Oncology

Increased Mortality Risk in Patients With Cancer Experiencing the Death of a Child

Vicki Moore, PhD

November 30, 2020

Population-based study evaluated survival outcomes for patients with cancer diagnosed over a 41-year period.

PRM-151 therapy well tolerated by patients with advanced myelofibrosis

Myeloproliferative Neoplasms

Conditioning With Alkylating Agents Prior to Transplant for Myelofibrosis

Vicki Moore, PhD

November 26, 2020

Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.

Increased travel burden is associated with a decreased likelihood of receiving adjuvant chemotherapy

Breast Cancer

Trends in End-of-Life Care in Women With Metastatic Breast Cancer

Vicki Moore, PhD

November 24, 2020

A recent analysis of insurance claims data revealed trends in ED visits, ICU visits, hospitalizations, and antineoplastic treatment at the end of life in this population.